Search

Your search keyword '"Tsai, Pei-Chien"' showing total 291 results

Search Constraints

Start Over You searched for: Author "Tsai, Pei-Chien" Remove constraint Author: "Tsai, Pei-Chien" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
291 results on '"Tsai, Pei-Chien"'

Search Results

1. Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan

2. Real-World Efficacy and Safety of Universal 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve Patients from a Nationwide HCV Registry in Taiwan

3. Severity of fatty liver is highly correlated with the risk of hypertension and diabetes: a cross-sectional and longitudinal cohort study

9. Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study

13. Enhanced resolution profiling in twins reveals differential methylation signatures of type 2 diabetes with links to its complications

15. Metabolomic biomarkers of habitual B vitamin intakes unveil novel differentially methylated positions in the human epigenome

18. Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry

20. Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study

21. Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging

26. Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort

32. Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan

34. THU-365 Real-world effectiveness and safety of 8-week glecaprevir/ pibrentasvir for treatment-naïve patients from Taiwan nationwide HCV registry

35. FRI-280 Dynamic of cardiometabolic components are highly correlated with the risk of hypertension and diabetes among patients with metabolic dysfunction-associated steatotic liver disease

36. FRI-271 Hepatitis C infection increases the risk of new-onset HTN and DM among patients with metabolic dysfunction-associated steatotic liver disease

37. Innovative technologies on the fabrication of 3D/4D smart hydrogels and its biomedical applications - A compendious review

39. Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4–6 infection: Real-world evidence from a nationwide registry in Taiwan

40. Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR)

41. Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan

42. Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study

43. DNA methylation signature of chronic low-grade inflammation and its role in cardio-respiratory diseases

44. Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine

45. The efficacy of multi‐disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patients

46. The benefits of hepatitis C viral eradication: a real-world nationwide cohort study in Taiwan

49. Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)

50. The Oncolytic Avian Reovirus p17 Protein Inhibits Invadopodia Formation in Murine Melanoma Cancer Cells by Suppressing the FAK/Src Pathway and the Formation of theTKs5/NCK1 Complex.

Catalog

Books, media, physical & digital resources